Skip to main content

Publications

featured publications

  • Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of age.

    Leukemia

    Authors: Elias K Mai, Kaya Miah, Uta Bertsch, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Markus Munder, Hans-Walter Lindemann, Maximilian Merz, Dirk Hose, Anna Jauch, Anja Seckinger, Steffen Luntz, Sandra Sauer, Stephan Fuhrmann, Peter Brossart, Ahmet Elmaagacli, Martin Goerner, Helga Bernhard, Martin Hoffmann, Marc S Raab, Igor W Blau, Mathias Hänel, Axel Benner, Hans J Salwender, Hartmut Goldschmidt

  • Selective BET-bromodomain inhibition by JQ1 suppresses dendritic cell maturation and antigen-specific T-cell responses.

    Cancer immunology, immunotherapy : CII

    Authors: Niklas Remke, Savita Bisht, Sebastian Oberbeck, Jens Nolting, Peter Brossart

  • Prognostic and predictive value of PD-L2 DNA methylation and mRNA expression in melanoma.

    Clinical epigenetics

    Authors: Friederike Hoffmann, Romina Zarbl, Dennis Niebel, Judith Sirokay, Anne Fröhlich, Christian Posch, Tobias A W Holderried, Peter Brossart, Gonzalo Saavedra, Pia Kuster, Sebastian Strieth, Gerrit H Gielen, Sandra S Ring, Jörn Dietrich, Torsten Pietsch, Lukas Flatz, Glen Kristiansen, Jennifer Landsberg, Dimo Dietrich

  • Towards new horizons: characterization, classification and implications of the tumour antigenic repertoire.

    Nature reviews. Clinical oncology

    Authors: Sebastian P Haen, Markus W Löffler, Hans-Georg Rammensee, Peter Brossart

  • The Role of Antigen Spreading in the Efficacy of Immunotherapies.

    Clinical cancer research : an official journal of the American Association for Cancer Research

    Authors: Peter Brossart

  • Treatment Response Monitoring in Patients with Advanced Malignancies Using Cell-Free SHOX2 and SEPT9 DNA Methylation in Blood: An Observational Prospective Study.

    The Journal of molecular diagnostics : JMD

    Authors: Luka de Vos, Maria Jung, Ruth-Miriam Koerber, Emma G Bawden, Tobias A W Holderried, Jörn Dietrich, Friedrich Bootz, Peter Brossart, Glen Kristiansen, Dimo Dietrich

  • Long-term follow-up of Cladribine, high-dose Cytarabine, and Idarubicin as salvage treatment for relapsed acute myeloid leukemia and literature review.

    European journal of haematology

    Authors: Karin Mayer, Corinna Hahn-Ast, Katjana Schwab, Ingo G H Schmidt-Wolf, Peter Brossart, Axel Glasmacher, Marie von Lilienfeld-Toal

  • Response-adapted lenalidomide maintenance in newly diagnosed myeloma: results from the phase III GMMG-MM5 trial.

    Leukemia

    Authors: Hartmut Goldschmidt, Elias K Mai, Jan Dürig, Christof Scheid, Katja C Weisel, Christina Kunz, Uta Bertsch, Thomas Hielscher, Maximilian Merz, Markus Munder, Hans-Walter Lindemann, Barbara Hügle-Dörr, Diana Tichy, Nicola Giesen, Dirk Hose, Anja Seckinger, Stefanie Huhn, Steffen Luntz, Anna Jauch, Ahmet Elmaagacli, Bernhard Rabold, Stephan Fuhrmann, Peter Brossart, Martin Goerner, Helga Bernhard, Martin Hoffmann, Jens Hillengass, Marc S Raab, Igor W Blau, Mathias Hänel, Hans J Salwender

  • Systemic Therapy of Neuroendocrine Neoplasia: Single Center Experience from a Cohort of 110 Consecutive Cases.

    International journal of endocrinology

    Authors: Karin Mayer, Selina Kiry, Anna Yordanova, Hojjat Ahmadzadehfar, Florian C Gaertner, Ralph A Bundschuh, Markus Essler, Maria A Gonzalez-Carmona, Christian P Strassburg, Hanno Matthaei, Philipp Lingohr, Savita Bisht, Peter Brossart, Georg Feldmann

  • Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine

    Authors: Susanne Lütje, Georg Feldmann, Markus Essler, Peter Brossart, Ralph A Bundschuh